Transforming Metabolic Dysfunction-Associated Steatohepatitis Management: Pharmacist Considerations for the Evolving Treatment Landscape

Summary: There is a new, free training program for pharmacists about a growing health problem called MASH (Metabolic Dysfunction-Associated Steatohepatitis). MASH is a serious type of fatty liver disease linked to metabolic issues, and it is a leading reason people need liver transplants.

In the past, the main treatment was just changing diet and exercise, which often didn't work well enough. Now, there are new treatments available, including a recently FDA-approved pill and other medicines like GLP-1s that are being tested. This 1.5-hour online course helps specialty pharmacists learn how to spot patients at risk, understand the newest guidelines, and use these new medicines to give patients better care.

For more details, see rssapp-drugtopics-com at pharmacytimes.org/courses/transforming-metabolic-dysfunction-associated-steatohepatitis-management-pharmacist-considerations-for-the-evolving-treatment-landscape-qjji?utm_source=drugtopics&utm_medium=homePage&utm_campaign=cmeDeck (opens in new tab)